Detalles de la búsqueda
1.
Effectiveness of first-line cetuximab in wild-type RAS metastatic colorectal cancer according to tumour BRAF mutation status from the EREBUS cohort.
Br J Clin Pharmacol
; 87(3): 1120-1128, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32656857
2.
Budget Impact of Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia With Sustained Deep Molecular Response.
Value Health
; 24(5): 683-690, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33933237
3.
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.
BMC Med Res Methodol
; 21(1): 95, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33933001
4.
Nurses' internal contamination by antineoplastic drugs in hospital centers: a cross-sectional descriptive study.
Int Arch Occup Environ Health
; 94(8): 1839-1850, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34021808
5.
Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort.
Br J Cancer
; 121(12): 1001-1008, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31719685
6.
Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study.
Pharmacoepidemiol Drug Saf
; 26(12): 1561-1569, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28573786
7.
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients.
Dig Liver Dis
; 2024 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38233313
8.
Strong instrumental variables biased propensity scores in comparative effectiveness research: A case study in oncology.
J Clin Epidemiol
; 155: 31-38, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36657590
9.
Clustering of prostate cancer healthcare pathways in the French National Healthcare database.
Cancer Innov
; 2(1): 52-64, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38090372
10.
Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer.
Target Oncol
; 18(5): 717-726, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37682504
11.
Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database.
Expert Rev Clin Pharmacol
; 15(9): 1139-1145, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35984212
12.
Patterns of quadruple therapy use including bismuth for Helicobacter pylori eradication: A cohort study in the French national claims database.
Therapie
; 76(5): 435-440, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33334580
13.
Noninferiority of cetuximab every-2-weeks versus standard once-weekly administration schedule for the first-line treatment of RAS wild-type metastatic colorectal cancer.
Eur J Cancer
; 144: 291-301, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33383349
14.
Quality of Life and Pain During Treatment of Metastatic Castration-resistant Prostate Cancer With Cabazitaxel In Routine Clinical Practice.
Clin Genitourin Cancer
; 18(5): e510-e516, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32229267
15.
Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare database.
Cancer Epidemiol
; 69: 101833, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33068878
16.
Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study.
BMJ Open
; 9(11): e033040, 2019 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31712349
17.
Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study.
Drug Saf
; 42(8): 993-1003, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31069703
18.
Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study.
Clin Colorectal Cancer
; 18(1): e150-e162, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30630730
19.
Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour location.
Eur J Cancer
; 180: 85-88, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36563490
20.
Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort.
Clin Colorectal Cancer
; 17(2): 129-139, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29523416